Isracann Biosciences(OTC) ISCNF

Current Price$0.00

Market CapN/A

Since IPO (2019)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Isracann Biosciences last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-07-21

Isracann Biosciences stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-07-14
1 month	+0%	USD 0.00	2026-06-18
3 month	+0%	USD 0.00	2026-04-20
Year to date	+0%	USD 0.00	2025-12-30
1 year	+0%	USD 0.00	2025-07-17
3 year	-100%	USD 0.02	2023-07-21
5 year	-100%	USD 0.17	2021-07-22
Since inception	-100%	USD 0.23	2019-10-18

Isracann Biosciences Financials at a Glance

Market Cap

N/A

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$4.54M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-339.83 (Low)

Dividend

$0.00

Beta (Volatility)

-339.83 (Low)

Price

$0.00

Volume

2,000

Open

$0.00

Price

$0.00

Volume

2,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Oct 7, 2024

Dividend

$0.00

Beta (Volatility)

-339.83 (Low)

Price

$0.00

Volume

2,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Oct 7, 2024

ISCNF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Isracann Biosciences

Isracann Biosciences Inc. is a Canadian company focused on the growth and supply of medical-grade cannabis in Israel. The firm is also engaged in establishing new cultivation infrastructure and exporting products internationally, particularly to Germany.

Products and Services

Medical-grade cannabis cultivation and supply
International product shipping, primarily to Germany
Development of cultivation infrastructure in Israel

Growth Outlook

Expansion into international markets enhances revenue potential
Investment in cultivation infrastructure supports long-term growth
Increasing global demand for medical cannabis presents opportunities

Financial Highlights

Recent quarterly net income reported at -315,995 CAD
Trailing twelve months (TTM) cash and cash equivalents at 198,054 CAD
Current ratio stands at 0.38, indicating liquidity challenges

Isracann Biosciences Inc. operates in the specialized drug manufacturing sector, focusing on medical cannabis. The company has made significant strides in establishing its presence in the Israeli market while also exploring international opportunities. The recent financial data indicates a net loss, reflecting ongoing investments in infrastructure and market development. The current ratio suggests liquidity challenges, which may impact short-term operational flexibility. However, the company's strategic focus on expanding its cultivation capabilities and entering new markets positions it for potential growth in the evolving cannabis industry.

AI Generated • Jun 29, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Philippe Floucault

Website

www.isracann.com

Headquarters

Vancouver, BC V7X 1L3, CA

ISCNF Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-221.78%

Return on Capital

-814.63%

Return on Assets

-114.73%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

2.00K

Avg. Volume

2.47K

Financials (TTM)

Gross Profit

-CA$41.73K

Operating Income

-CA$2.34M

EBITDA

-CA$4.50M

Operating Cash Flow

-CA$1.48M

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$1.48M

Cash & ST Invst.

CA$198.05K

Total Debt

CA$0.00

Isracann Biosciences Performance Analysis

Isracann Biosciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-05-31	CAD 0	N/A

Isracann Biosciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2021-11-30	N/A
Q3	2022-02-28	N/A
Q4	2022-05-31	N/A
Q1	2022-08-31	N/A

Isracann Biosciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-05-31	CAD -0.03	N/A

Isracann Biosciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2021-11-30	-87.5%
Q3	2022-02-28	30.0%
Q4	2022-05-31	-309.5%
Q1	2022-08-31	88.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2023YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$10.43K

+0.0%

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-CA$316.00K

+32.6%

EBITDA

-CA$305.56K

+31.2%

Quarterly Fundamentals

Name

Q1 2023YOY CHG

Total Cash

CA$198.05K

-85.8%

Total Debt

CA$0.00

N/A

Accounts Receivable

CA$83.21K

-14.9%

Inventory

CA$0.00

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$0.00

N/A

Return on Assets

-1.15%

N/A

Return on Invested Capital

-0.08%

N/A

Free Cash Flow

-CA$163.40K

+63.1%

Operating Cash Flow

-CA$163.40K

+63.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RAPHRaphael Pharmaceutical Inc.

RAPHRaphael Pharmaceutical Inc.$1.40+0.00%

GBLPGlobal Pharmatech, Inc.

GBLPGlobal Pharmatech, Inc.$0.08+0.00%

MEDIFMediPharm Labs Corp.

MEDIFMediPharm Labs Corp.$0.06+1.79%

AVCNFAvicanna Inc.

AVCNFAvicanna Inc.$0.10+8.60%

MRESInstitute of Biomedical Research Corp.

MRESInstitute of Biomedical Research Corp.$0.00+0.00%

CWBHFCharlotte's Web Holdings, Inc.

CWBHFCharlotte's Web Holdings, Inc.$0.22-2.42%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TAT&T

TAT&T$23.04+0.04%

ONDSOndas

ONDSOndas$8.00+0.04%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.79-0.03%

PATHUiPath

PATHUiPath$10.70-0.11%

NOKNokia

NOKNokia$10.28-0.03%

SOFISoFi Technologies

SOFISoFi Technologies$17.07-0.03%

FFord Motor Company

FFord Motor Company$14.42+0.01%

Questions About ISCNF

What is the current price of Isracann Biosciences?

Isracann Biosciences is trading at $0.00 per share.

What is the 52-week range for Isracann Biosciences?

Over the past 52 weeks, Isracann Biosciences has traded between $0.00 and $0.00.

How much debt does Isracann Biosciences have?

As of the most recent reporting period, Isracann Biosciences reported total debt of CA$0.00.

How much cash does Isracann Biosciences have on hand?

Isracann Biosciences reported CA$169.14K in cash and cash equivalents in its most recent financial results.

What is Isracann Biosciences’s dividend yield?

Isracann Biosciences does not currently have a dividend yield.

Isracann Biosciences(OTC) ISCNF

Isracann Biosciences Financials at a Glance

ISCNF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Isracann Biosciences

ISCNF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Isracann Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ISCNF

What is the current price of Isracann Biosciences?

What is the 52-week range for Isracann Biosciences?

How much debt does Isracann Biosciences have?

How much cash does Isracann Biosciences have on hand?

What is Isracann Biosciences’s dividend yield?

Premium Investing Services